Sieving, Separation, Filtration and Ultrasonic Systems
Browells Lane, Middlesex, Feltham, TW13 7EW, United Kingdom
Russell Finex are experts in fine mesh separation technology, having been designing and manufacturing sieves, separators, self-cleaning in-line filters, and ultrasonic systems for 80 years.
With innovation at the core of the business, Russell Finex are continually developing its range of sieves and filters alongside its manufacturing procedures to satisfy demanding requirements of the pharmaceutical industry.
Also known as safety screeners or control sieves, check screeners ensure correct product quality of powders or liquids is achieved through removing oversize contamination. Products in this range include the Compact Sieve®, the Compact 3in1™ and Blow Thru Sieve™.
Grading / sizing of powders and granules achieves separation on different ranges of particle sizes. Grading machines separate up to five product fractions, increasing sieving accuracy and efficiency, and includes the Finex Separator™, Russell Eco Separator® and the Finex range.
The Compact Airlock Sieve™ and the Compact Airswept Sieve™ are designed to provide accurate removal of oversize contamination, with maximum product containment. This delivers improved product quality while safeguarding your operators’ health. The current good manufacturing practice (cGMP) design of these sieves is based on clean lines, making sanitation easier and enhancing performance.
Ultrasonic sieve deblinding systems are used to eliminate mesh blinding and blockage, which is a common problem when sieving dry powders. The Vibrasonic® Deblinding System uses ultrasonic frequency, enabling finer meshes to be used and increasing screening capacity. It has revolutionised the screening of difficult powders on sieve meshes, allowing accurate separation down to 20µm. The ultrasonic system has been designed to be retrofitted on to any sieve / separator.
Russell Finex’s range of self-cleaning in-line filters are ideal for removing oversize contamination from liquids and provide consistently high flow rates, with no operator control necessary. As they do not require filter bags or cartridges and significantly reduce wasted products, the company’s in-line filters are both cost-effective and environmentally friendly. The filter range includes vertical, horizontal, in-line, on-line, high-temperature / jacketed filters and the Filter Management System™.
For more than 50 years, Russell Finex has been carrying out extensive market research and working in partnership with the world’s major pharmaceutical manufacturers, such as GSK, Pfizer, Wyeth, and Sanofi Aventis to ensure the company understands how to meet high standards of design, usability, and performance.
All Russell Finex’s pharmaceutical equipment is manufactured using the highest possible quality 316L grade stainless steel, ensuring metal impurities are reduced to a minimum. In addition, its specialist polishing techniques allow the company to offer the highest standard mirror polished finish to a documented Ra 0.1. This, combined with easily dismantled parts, ensures all equipment can be easily and thoroughly cleaned.
With companies in the UK, the US, and Belgium, as well as a strong network of experienced agents and distributors worldwide, the equipment is engineered for a global market supplied to over 140 countries.
Cipla's new OEL compliant plant was built for the manufacture of a new highly potent drug and as with nearly all processes handling pharmaceutical powders, to ensure specification and quality were upheld a number of sieving operations were required.
Russell Finex and Powder Systems Limited (PSL) have collaborated to combine the Russell Compact Sieve® with a high-containment isolator to make an innovative screening solution for pharmaceutical manufacturers.
ESTEVE, a leading Spanish chemical-pharmaceutical group, invests heavily in Research & Development of new formulations and commercialises medicines and innovative formulations to achieve a high level of excellence in the healthcare market.
Dealing with pharmaceutical ingredients demands adherence to a range of health and safety regulations. A sieve or screener is a crucial part of every pharmaceutical production process, particularly as product quality and integrity are essential.
A high-efficiency gyratory sifter improves product quality and reduces machine downtime at Windlas’ pharmaceutical facility.
Howorth Air Technology (Howorth) engineers a range of powder containment solutions and aseptic systems for medical, pharmaceutical and other industries. The company manufactures high-quality bespoke products and turnkey systems to clients throughout Europe, Asia and the Americas.
Industrial sieving with the Russell Compact Airswept Sieve minimises the risk of contamination when screening in batches.
Pharmaceutical chalk is processed through the Finex 22™ with ultrasonic technology to prevent blockage, which increases production speeds.
Vibrating screen with Russell Vibrasonic® Deblinding System separates oversize grains in each batch to maintain product quality.
Russell Compact Sieve is a highly contained isolator, providing full coverage for operators.
GlaxoSmithKline installs a vibrating screener fitted with the Vibrasonic® Deblinding System to increase productivity.
Two Russell Compact Sieve® units are installed to increase productivity and screen incoming raw materials.
When processing active pharmaceutical ingredients (APIs), the occupational exposure limit (OEL) has a significant part to play in the design of a process to ensure operators are not at risk to exposure.
Contained sieving equipment for pharmaceutical powders prevents contamination at Howorth Air Technology.
Being the leading exhibition for powder, granule and bulk solids technologies, POWTECH offers a unique overview of current mechanical processing technologies and equipment for a variety of industries.
Due to ATEX directives, containment during the processing and transfer of pharmaceutical powders is a high priority, and various measures must be in place to account for explosion risk.
When Enzymatic Therapy stopped outsourcing and built its own US Food and Drug Administration (FDA) approved manufacturing facility, the goal was to improve product quality, streamline production and ramp up sales growth.
Sri Krishna Pharmaceuticals is an established manufacturer of pharmaceutical products such as acetaminophen (paracetamol), folic acid, domperidone and furosemide, supplying more than 150 niche drugs to the Asian pharmaceutical market, Europe and the US.
Manufacturer of containment and aseptic systems Extract Technology has integrated Russell Finex’s separation equipment to optimise powder production.
Spanish chemical-pharmaceutical group ESTEVE invests heavily in the research and development (R&D) of new formulations and commercialises medicines and innovative formulations to achieve a high level of excellence in the healthcare market.
Russell Finex’s circular vibrating screens with ultrasonic screening technology remove oversized particles during the processing of face powders.
Howorth Air Technology engineers a range of powder containment solutions and aseptic systems for medical, pharmaceutical and other industries. The company manufactures high-quality bespoke products and turnkey systems to clients throughout Europe, Asia and the Americas.
Powder Systems Limited (PSL) holds a wealth of experience engineering containment processes, supplying high-quality customised process equipment to worldwide pharmaceutical, chemical, and laboratory industries.
Due to ATEX directives, containment during the processing and transfer of pharmaceutical powders is a high priority, and various measures must be in place to account for explosion risk.
Sri Krishna Pharmaceuticals is an established manufacturer of pharmaceutical products such as acetaminophen (paracetamol), folic acid, domperidone and furosemide, supplying more than 150 niche drugs to the Asian pharmaceutical market, as well as Europe and the US.
Extract Technology is a containment and aseptic systems manufacturer supplying customised solutions to a global network of pharmaceutical and chemical manufacturers.
GSK is improving process efficiency in the production of pharmaceutical powders at its Centre of Excellence plant in Dartford, Kent, by investing in nine new industrial pharmaceutical sieves fitted with the Vibrasonic deblinding system from Russell Finex.
Screen blocking or blinding is a common problem when sieving fine pharmaceutical powders on screens of 300 microns and below.
Russell Finex has been selected to represent the manufacturing industry in this year's Parliamentary Review.
Russell Finex has been innovating processing technology since 1934, and is celebrating 80 years of growth and excellence.
Raising the bar in the dietary supplement industry to pharmaceutical standards, Enzymatic Therapy has relied on compact vibratory screeners to optimise product quality and production while meeting growing demand. When Enzymatic Therapy stopped outsourcing and built its own FDA-approved
GlaxoSmithKline is improving process efficiency in the production of pharmaceutical powders at its 'centre of excellence' plant in Dartford, Kent, following the installation of nine new high-performance vibratory separators fitted with the Vibrasonic® Deblinding System, supplied by Russell F
Sieves or screeners are an essential part of every pharmaceutical production process, particularly as product quality and integrity are so important. The use of sieves safeguards against customer compensation or litigation, as it eliminates all oversized contamination. It therefore ensures that i
Cipla of India relies on the revolutionary Compact Airlock Sieve® to ensure their new highest OEL-compliant plant is not jeopardised during the screening operation. Screening equipment is an integral part of most pharmaceutical processes; it ensures that ingredients and finished pr
Fine mesh separation and filtration specialist Russell Finex has introduced the new Compact Airlock Sieve, adding a new dimension to screening technology for the pharmaceutical industry. The unique design has evolved as a result of close consultation with many of the top pharmaceutical companies
Browells Lane
Middlesex
Feltham
TW13 7EW
United Kingdom